© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Blood-Based Colorectal Cancer Screening Test Achieves 95% Patient Adherence in Real-World Study
November 19, 2025
Real-world data from 20 000 patients demonstrate significantly higher adherence rates with Shield blood test vs colonoscopy and stool-based screening methods.
FDA Approves Deep Transcranial Magnetic Stimulation Device for MDD Treatment in Youth Ages 15 to 21, BrainsWay Announces
November 19, 2025
Deep TMS becomes first FDA-cleared brain stimulation therapy for adolescents with treatment-resistant depression and is now available for ages 15-86 for MDD treatment.
Reinterpreting WHI and Rethinking GSM: Insights from Caroline Mitchell, MD, MPH
November 18, 2025
TMS: Harvard's Caroline Mitchell, MD, MPH, questions the direction of genitourinary syndrome research priorities and reflects on FDA's removal of HRT warnings.
Autoimmune Disease Risk After HT: Clinical Insights From a Large Real-World Study
November 18, 2025
Study author Daniel Jiang, MD, PhD, discusses data linking hormone therapy to increased autoimmune disease risk in postmenopausal women and clinical implications.
New Online Tool Calculates Percentiles for 30-Year Cardiovascular Disease Risk in Younger Adults
November 18, 2025
Northwestern University unveils a groundbreaking online tool that helps younger adults understand their 30-year cardiovascular disease risk through percentile rankings.
How Neurodivergent Adults View Neurodiversity Terminology: Findings From a Large UK Survey
November 18, 2025
UK neurodivergent adults report strong views on neurodiversity terminology, emphasizing correct usage and its role in stigma, identity, and communication.
Preventive Health Inventory Boosts Diabetes and Hypertension Management Without Increasing Hospitalizations Among Veterans: New Study
November 18, 2025
A new study reveals that the Preventive Health Inventory enhances diabetes and hypertension management among veterans without increasing hospitalizations.
For GLP-1 Medication Users, Investigational NK-1 Agent May Quell GI Side Effects by Half
November 18, 2025
In the phase 2 clinical trial, tradipitant, an oral neurokinin-1 receptor antagonist, was dosed twice daily among adults with obesity and treated with semaglutide.
Chronic Pain Linked to Greater Risk of Hypertension, Depression Mediates the Relationship
November 17, 2025
Individuals who have chronic widespread pain showed a 75% increased risk of developing hypertension compared to fellow UK Biobank participants who were pain-free.
Alcohol Use at Any Level Tied to Increased Risk of Dementia: Daily Dose
November 17, 2025
Your daily dose of the clinical news you may have missed.